US 12428470
Compositions containing activatable antibodies
granted A61PA61P35/00
Quick answer
US patent 12428470 (Compositions containing activatable antibodies) held by CytomX Therapeutics, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61P, A61P35/00